Literature DB >> 33807720

5-Hydroxytryptamine Modulates Maturation and Mitochondria Function of Human Oligodendrocyte Progenitor M03-13 Cells.

Simona Damiano1, Giuliana La Rosa1, Concetta Sozio1, Gina Cavaliere2, Giovanna Trinchese2, Maddalena Raia3, Roberto Paternò1, Maria Pina Mollica2, Vittorio Enrico Avvedimento3, Mariarosaria Santillo1.   

Abstract

Inside the adult CNS, oligodendrocyte progenitor cells (OPCS) are able to proliferate, migrate and differentiate into mature oligodendrocytes (OLs) which are responsible for the production of myelin sheet and energy supply for neurons. Moreover, in demyelinating diseases, OPCs are recruited to the lesion areas where they undergo differentiation and myelin synthesis. Serotonin (5-hydroxytryptamine, 5-HT) is involved in OLs' development and myelination, but so far the molecular mechanisms involved or the effects of 5-HT on mitochondria function have not yet been well documented. Our data show that 5-HT inhibits migration and proliferation committing cells toward differentiation in an immortalized human oligodendrocyte precursor cell line, M03-13. Migration blockage is mediated by reactive oxygen species (ROS) generation since antioxidants, such as Vit C and Cu-Zn superoxide dismutase, prevent the inhibitory effects of 5-HT on cell migration. 5-HT inhibits OPC migration and proliferation and increases OL phenotypic markers myelin basic protein (MBP) and Olig-2 via protein kinase C (PKC) activation since the inhibitor of PKC, bis-indolyl-maleimide (BIM), counteracts 5-HT effects. NOX inhibitors as well, reverse the effects of 5-HT, indicating that 5-HT influences the maturation process of OPCs by NOX-dependent ROS production. Finally, 5-HT increases mitochondria function and antioxidant activity. The identification of the molecular mechanisms underlying the effects of 5-HT on maturation and energy metabolism of OPCs could pave the way for the development of new treatments for autoimmune demyelinating diseases such as Multiple Sclerosis where oligodendrocytes are the primary target of immune attack.

Entities:  

Keywords:  5-hydroxytryptamine; NOX; differentiation; migration; mitochondria; oligodendrocyte precursor cells; proliferation; reactive oxygen species

Mesh:

Substances:

Year:  2021        PMID: 33807720      PMCID: PMC7962057          DOI: 10.3390/ijms22052621

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  96 in total

1.  Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.

Authors:  M Bonora; E De Marchi; S Patergnani; J M Suski; F Celsi; A Bononi; C Giorgi; S Marchi; A Rimessi; J Duszyński; T Pozzan; M R Wieckowski; P Pinton
Journal:  Cell Death Differ       Date:  2014-03-21       Impact factor: 15.828

2.  Analysis and interpretation of microplate-based oxygen consumption and pH data.

Authors:  Ajit S Divakaruni; Alexander Paradyse; David A Ferrick; Anne N Murphy; Martin Jastroch
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

3.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  Cu-Zn superoxide dismutase activates muscarinic acetylcholine M1 receptor pathway in neuroblastoma cells.

Authors:  Simona Damiano; Tiziana Petrozziello; Valentina Ucci; Stefano Amente; Mariarosaria Santillo; Paolo Mondola
Journal:  Mol Cell Neurosci       Date:  2012-11-10       Impact factor: 4.314

5.  Diabetes inhibits corneal epithelial cell migration and tight junction formation in mice and human via increasing ROS and impairing Akt signaling.

Authors:  Qi-Wei Jiang; Denis Kaili; Jonaye Freeman; Chong-Yang Lei; Bing-Chuan Geng; Tao Tan; Jian-Feng He; Zhi Shi; Jian-Jie Ma; Yan-Hong Luo; Heather Chandler; Hua Zhu
Journal:  Acta Pharmacol Sin       Date:  2019-03-13       Impact factor: 6.150

6.  The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages.

Authors:  Hirohide Takebayashi; Yoko Nabeshima; Shosei Yoshida; Osamu Chisaka; Kazuhiro Ikenaka; Yo-ichi Nabeshima
Journal:  Curr Biol       Date:  2002-07-09       Impact factor: 10.834

7.  Vitamin C promotes oligodendrocytes generation and remyelination.

Authors:  Yu-E Guo; Na Suo; Xue Cui; Qianting Yuan; Xin Xie
Journal:  Glia       Date:  2018-02-09       Impact factor: 7.452

Review 8.  Adenosine Actions on Oligodendroglia and Myelination in Autism Spectrum Disorder.

Authors:  Hai-Ying Shen; Nanxin Huang; Jesica Reemmer; Lan Xiao
Journal:  Front Cell Neurosci       Date:  2018-12-07       Impact factor: 5.505

9.  Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3.

Authors:  Jaewon J Lee; Robert A H van de Ven; Elma Zaganjor; Mei Rosa Ng; Amey Barakat; Joris J P G Demmers; Lydia W S Finley; Karina N Gonzalez Herrera; Yin Pun Hung; Isaac S Harris; Seung Min Jeong; Gaudenz Danuser; Sandra S McAllister; Marcia C Haigis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

10.  Oligodendrocyte Bioenergetics in Health and Disease.

Authors:  Lauren Rosko; Victoria N Smith; Reiji Yamazaki; Jeffrey K Huang
Journal:  Neuroscientist       Date:  2018-08-20       Impact factor: 7.519

View more
  3 in total

Review 1.  Activation of SIRT-1 Signalling in the Prevention of Bipolar Disorder and Related Neurocomplications: Target Activators and Influences on Neurological Dysfunctions.

Authors:  Bidisha Rajkhowa; Sidharth Mehan; Pranshul Sethi; Aradhana Prajapati
Journal:  Neurotox Res       Date:  2022-02-14       Impact factor: 3.911

Review 2.  Psychedelic-inspired approaches for treating neurodegenerative disorders.

Authors:  Hannah N Saeger; David E Olson
Journal:  J Neurochem       Date:  2021-12-05       Impact factor: 5.546

3.  Protein Kinase C Activation Drives a Differentiation Program in an Oligodendroglial Precursor Model through the Modulation of Specific Biological Networks.

Authors:  Marina Damato; Tristan Cardon; Maxence Wisztorski; Isabelle Fournier; Damiana Pieragostino; Ilaria Cicalini; Michel Salzet; Daniele Vergara; Michele Maffia
Journal:  Int J Mol Sci       Date:  2021-05-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.